Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts
Deregulations of the expression of the S100A8 and S100A9 genes and/or proteins, as well as changes in their plasma levels or their levels of secretion in the bone marrow microenvironment, are frequently observed in acute myeloblastic leukemias (AML) and acute lymphoblastic leukemias (ALL). These der...
Main Authors: | Julie Mondet, Simon Chevalier, Pascal Mossuz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/5/1323 |
Similar Items
-
The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression
by: Chi-Yuan Yao, et al.
Published: (2023-07-01) -
Increased plasma levels of S100A8, S100A9, and S100A12 in chronic spontaneous urticaria
by: Qiong-Yan Zhou, et al.
Published: (2019-01-01) -
FAT1 Gene Expression in Iranian Acute Lymphoid and Myeloid Leukemia Patients
by: Mohammadreza Ostadali Dehaghi, et al.
Published: (2023-04-01) -
Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes
by: Carolin Christmann, et al.
Published: (2021-02-01) -
S100A8/A9 in Inflammation
by: Siwen Wang, et al.
Published: (2018-06-01)